Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study.
Saved in:
| Title: | Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study. |
|---|---|
| Authors: | Maffezzoli M; Medicine and Surgery Department, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Signori A; Department of Health Sciences, Section of Biostatistics, University of Genova, Genoa, Italy., Acunzo A; Medicine and Surgery Department, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Buti S; Medicine and Surgery Department, University of Parma, Parma, Italy. sebastiano.buti@unipr.it.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy. sebastiano.buti@unipr.it., Bosoni M; Medicine and Surgery Department, University of Parma, Parma, Italy., Verzoni E; Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Marco A; Oncology 1 Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy., Lolli C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Di Napoli M; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Fanelli M; Department of Medicine (DAME), University of Udine, Udine, Italy., Volta AD; Unit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy., Masini C; Medical Oncology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Firenze, Florence, Italy., Iacovelli R; Facoltà di Medicina e Chirurgia, Rome, Italy.; Medical Oncology, Università Cattolica del Sacro Cuore, Fondazione Policlinico, Universitario Agostino Gemelli IRCCS, Rome, Italy., Mennitto A; Department of Medical Oncology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Novara, Italy., Filippi R; Medical Oncology 1U, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy., Sorarù M; U.O. Oncologia, Ospedale di Camposampiero, Camposampiero, Italy., Formisano L; Division of Pharmacology, Department of Neuroscience, Reproductive and Dentistry Sciences, School of Medicine, Federico II University of Naples, Naples, Italy., Guida A; Medical Oncology Unit, Santa Maria Hospital, Terni, Italy., Fantinel E; Department of Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, University of Verona, Verona, Italy., Messina C; Clinical Oncology, Ospedale Arnas Civico, Palermo, Italy., Bonomi L; Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Scagliarini S; Department of Medical Oncology, AORN 'A. Cardarelli', Naples, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, Pietra Ligure, Italy., Chiellino S; Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy., Maiorano BA; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Deppieri F; Medical Oncology Unit, AULSS 3 Serenissima, Mestre-Venice, Italy., Cavo A; Oncology Unit, ASL3- Villa Scassi Hospital, Genoa, Italy., Conteduca V; nit of Medical Oncology and Biomolecular Therapy and CREATE Center for Research and Innovation in Medicine, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy., Zai S; Medical Oncology Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Zucali PA; Department of Biomedical Sciences, Department of Oncology, Humanitas University, Pieve Emanuele, Milan, Italy.; IRCCS, Humanitascxs Clinical and Research Center, Rozzano, Milano, Italy., Tucci M; Department of Medical Oncology, Cardinal Massaia Hospital, Asti, Italy., Vignani F; Division of Medical Oncology, Ordine Mauriziano Hospital, Turin, Italy., La Russa F; Ospedale San Bortolo, Ulss 8 Berica, Vicenza, Italy., Lombardo L; Oncology Unit, Deptartment of Onco-Ematology, Ramazzini Hospital, Carpi, Ausl Modena, Italy., Caserta C; Medical Oncology Unit, Santa Maria Della Misericordia Hospital, Perugia, Italy., Paolieri F; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Bertolotti F; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy., Rescigno P; Department of Oncology, Candiolo Cancer Institute FPO-IRCCS, Turin, Italy.; Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Banna GL; Department of Oncology, Portsmouth, Univeristy Hospitals NHS Trust, Portsmouth, UK.; Faculty of Science & Health, School of Pharmacy & Biomedical Sciences, University of Portsmouth, Portsmouth, UK., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Bimbatti D; Oncology 1 Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy., Rebuzzi SE; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Città della Salute e Della Scienza di Torino, Ospedale Molinette, Turin, Italy. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Feb 03; Vol. 75 (3), pp. 66. Date of Electronic Publication: 2026 Feb 03. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-026-04318-x |
